Full Press Release Details
ADVISORY, Dec. 08, 2017 (GLOBE NEWSWIRE) --
Denali Therapeutics Inc. (Nasdaq:DNLI), a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, will visit the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).
In honor of the occasion, Ryan Watts, Chief Executive Officer, will ring the Opening Bell.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Friday, December 8, 2017 – 9:15 a.m. to 9:30 a.m. ET
Denali Therapeutics Inc. Media Contact:
202-337-0808 office, 617-872-3655 mobile
Nasdaq MarketSite Media Contact:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:
For photos from ceremonies and events, please visit our Instagram page:
For livestream of ceremonies and events, please visit our YouTube page:
For news tweets, please visit our Twitter page:
For exciting viral content and ceremony photos, please visit our Tumblr page:
A live stream of the Nasdaq Opening Bell will be available at:
To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.
About Denali Therapeutics Inc.
Denali is a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases. Denali is based in South San Francisco. Denali Therapeutics is committed to developing therapies for neurodegeneration, one of the most significant unmet medical needs of our time. Denali Therapeutics relies on its core principles of identifying and selecting targets based on validated genetic drivers of neurodegeneration, developing medicines that effectively cross the blood-brain barrier and target the brain, and developing and using biomarkers for better patient selection and demonstration of target and pathway engagement of our product candidates in order to succeed in a field that has seen limited progress in the past several decades.
Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com